Spots Global Cancer Trial Database for transarterial chemoembolization (tace)
Every month we try and update this database with for transarterial chemoembolization (tace) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| DCE-MRI for Assessment of Response to TACE of HCC | NCT02878109 | Carcinoma, Hepa... | Post-treatment ... Pre-treatment p... | 18 Years - | Centre hospitalier de l'Université de Montréal (CHUM) | |
| Efficacy of Sequential TACE and PVE on the Resectability of Hepatitis B Related HCC | NCT00834158 | Hepatocellular ... | TACE PVE | 20 Years - 65 Years | Eastern Hepatobiliary Surgery Hospital | |
| A Study of TACE Combined With Atezolizumab Plus Bevacizumab or TACE Alone in Patients With Untreated Heaptocellular Carcionma | NCT04712643 | Hepatocellular ... | Atezolizumab Becavizumab Transarterial c... | 18 Years - | Hoffmann-La Roche | |
| Comparison of Liver and Renal Function After Transarterial Chemoembolization for Primary Hepatocellular Carcinoma With Iso-osmolar Contrast Media and Low Osmolar Contrast Media | NCT01563484 | Primary Hepatoc... | 18 Years - 75 Years | Southeast University, China | ||
| Neoadjuvant TACiE in Locally Advanced Gastric Cancer | NCT05346874 | Gastric Cancer | Oxaliplatin Teysuno Transarterial c... | 18 Years - 75 Years | Shanghai Zhongshan Hospital | |
| A Clinical Study of Tislelizumab Combined With TACE and Lenvatinib in the Neoadjuvant Treatment of Resectable HCC | NCT06003673 | Hepatocellular ... | neoadjuvant the... | 18 Years - 75 Years | First Affiliated Hospital of Fujian Medical University | |
| Single Session Combined Locoregional Therapies for Hepatocellular Carcinoma | NCT02646137 | Liver Cancer | Transarterial c... Radiofrequency ... Microwave ablat... | 18 Years - 70 Years | Tanta University | |
| A Study of Comparison of TACE Combination With and Without EBRT for Advanced HCC | NCT03116984 | Hepatocellular ... | Transcatheter a... External- beam ... | 18 Years - | Shanghai Zhongshan Hospital | |
| Chemoembolization With or Without Stereotactic Body Radiosurgery for Liver Cancer | NCT02304445 | Carcinoma, Hepa... | Transarterial C... TACE+Stereotact... | 18 Years - 70 Years | Midwestern Regional Medical Center | |
| A Global Study to Evaluate Transarterial Chemoembolization (TACE) in Combination With Durvalumab and Bevacizumab Therapy in Patients With Locoregional Hepatocellular Carcinoma | NCT03778957 | Hepatocellular ... | Durvalumab Bevacizumab Placebo Transarterial C... | 18 Years - 110 Years | AstraZeneca | |
| Efficacy and Safety of Concurrent TACE and Sorafenib in Patients With HCC and Extrahepatic Metastasis (COTSOM Study) | NCT02311205 | Hepatocellular ... Metastasis | Conventional Tr... sorafenib | 20 Years - | Asan Medical Center | |
| Different Regimens of Transarterial Chemoembolization for Hepatocellular Carcinoma | NCT00493402 | Hepatocellular ... | Transarterial c... Transarterial c... Transarterial c... | 18 Years - 75 Years | Sun Yat-sen University | |
| A Study of TACE Combined With Atezolizumab Plus Bevacizumab or TACE Alone in Patients With Untreated Heaptocellular Carcionma | NCT04712643 | Hepatocellular ... | Atezolizumab Becavizumab Transarterial c... | 18 Years - | Hoffmann-La Roche | |
| Comparison of Liver and Renal Function After Transarterial Chemoembolization for Primary Hepatocellular Carcinoma With Iso-osmolar Contrast Media and Low Osmolar Contrast Media | NCT01563484 | Primary Hepatoc... | 18 Years - 75 Years | Southeast University, China | ||
| A Study to Evaluate Sintilimab Plus Lenvatinib as Adjuvant Therapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis (PVTT) After Surgical Resection | NCT06089382 | Hepatocellular ... | Sintilimab Lenvatinib Transarterial C... | 18 Years - 75 Years | Tongji Hospital | |
| The Long-term Efficacy of Imatinib With Hepatic Resection or Other Local Treatment for GIST Liver Metastases | NCT06038552 | GIST, Malignant Liver Metastase... | imatinib (IM) hepatic resecti... radiofrequency ... transarterial c... | 18 Years - 75 Years | First Affiliated Hospital, Sun Yat-Sen University | |
| Decrease in Circulating Tumour Cell Count Reflects the Effectiveness of Postoperative Adjuvant Transarterial Chemoembolization (TACE) in Preventing Hepatocellular Carcinoma Recurrence | NCT02032368 | Circulating Tum... Hepatocellular ... | transarterial c... | 18 Years - 75 Years | Guangdong Provincial People's Hospital | |
| A Phase 3 Trial Comparing TACE and TARE in Unilobar Advanced Hepatocellular Carcinoma | NCT02004210 | Hepatocellular ... | transarterial r... transarterial c... | 20 Years - 80 Years | Seoul National University Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
